Home Page Potential Lawsuit Diabetes Medication Side Effects Lawsuits
Diabetes Medication Lawsuits
The use of some diabetes medications has been linked in recent studies to an increased risk of diabetes medication side effects including a risk of thyroid cancer and/or pancreatic cancer. Lawsuits have been filed against the makers of some diabetes drugs, alleging patients were not adequately warned about the risks.
Among the diabetes medications possibly linked to an increased risk of thyroid and/or pancreatic cancer are:
Diabetes Medication Side Effects
Exenatide (Byetta, Bydureon)
Sitaglptin (Januvia, Janumet, Janumet XR, Juvisync)
Liraglutide (Victoza) Saxagliptin (Onglyza, Kombiglyze XR)
Alogliptin (Nesina, Kazano, Oseni)
Linagliptin (Tradjenta, Jentadueto)
The drugs are in a class of diabetes medication called incretin mimetic drugs because they mimic incretin hormones that are naturally produced in the body, and which stimulate the release of insulin following a meal.
On March 14, 2013, the FDA issued a Drug Safety Communication about the drugs noting that it was evaluating findings from researchers that suggested an increased risk of pancreatitis and pre-cancerous cellular changes in patients who used incretin mimetics. Pancreatitis is also associated with an increased risk of pancreatic cancer. At the time, the FDA said it had not reached new conclusions about the drugs, and said it has not concluded the drugs cause or contribute to pancreatic cancer.
Both exenatide and sitagliptin have also been linked in reports to fatal and nonfatal cases of acute pancreatitis. The FDA noted that one study found up to double the risk of acute pancreatitis in patients who used either of those drugs.
Byetta has been linked to an increased risk of acute pancreatitis, pancreatic cancer and thyroid cancer. The US Food and Drugs Administration (FDA) has issued warnings about Byetta, including reports of necrotizing or hemorrhagic pancreatitis, two of which resulted in death.
Byetta lawsuits have been filed against the maker of the drug, alleging patients developed pancreatic cancer after using the diabetes medication.
Januvia has been linked to an increased risk of acute pancreatitis. Between October 16, 2006, and February 9, 2009, the FDA reportedly received 88 post-marketing reports of acute pancreatitis linked to the medication. Of those, 66 were hospitalized and four were treated in the intensive care unit.
One study, published in the journal Gastroenterology (7/11) suggested a link between the use of Januvia and the development of pancreatitis and pancreatic cancer, but other researchers argued the study was flawed.
In March 2013, the FDA announced it was undertaking a safety review of Januvia, Byetta and Bydureon to determine the risk of pancreatitis in patients who used the medications. In addition, a motion has been filed with the US Judicial Panel on Multidistrict Litigation (MDL) to consolidate approximately 53 lawsuits that allege pancreatic cancer as a result of Januvia, Janumet, Byetta and Victoza.
In March 2013, the FDA announced that results from a study suggested Victoza was linked to an increased risk of pancreatitis. The FDA has not so far requested any changes to the Victoza label, but it has said it is reviewing data from the study. Meanwhile, animal studies suggest Victoza is linked to an increased risk of a rare thyroid cancer called medullary thyroid cancer.
Victoza is one of the diabetes drugs included in the motion filed with the US Judicial Panel on Multidistrict Litigation (MDL) that aims to consolidate diabetes drug lawsuits alleging pancreatic cancer as a result of taking Januvia, Janumet, Byetta or Victoza.
Diabetes Medication Side Effects Legal HelpIf you or a loved one has suffered Diabetes Medication damages or injuries, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Last updated on May-20-13
DIABETES MEDICATION LEGAL ARTICLES AND INTERVIEWS
Proving the Case - Pancreatic Cancer Patients Point Finger at Diabetes Drugs
Increased Disability with Diabetes - Will This Affect Disability Insurance Claims?
READ MORE [ Drugs/Medical Settlements and Legal News ]
READ MORE [ Personal Injury Settlements and Legal News ]
Dear sir, dear madame!
My name is Manuel Stuettler I´m 38 years old, 1,81 meters tall body
weight 78 kg.I´m a mycologist, head of Mushroom Research Center Austria
and my IQ was measured by a sworn authorised expert on psychiatry at 139
points. In the year 2012 I had a deep vein thrombosis in my right leg
due to long resting in the bed because i had an ankle injury.
I was treated then with Lovenox syringes for a few months . At first
there where no complications. But after a certain amount of time being
treated i developed severe muscle weakness so i was forced to use
crutches for walking. But the effect got even stronger until i was
unable to hold my body weight which led me to use a wheelchair.The
doctors in Innsbruck Austria, European Union didn´t recognize this side
effect as it was and still isn´t mentioned on the instruction leaflet in
Austria or Europe.After the Lovenox treatment the doctors switched to
Sintrom which led to a discoordination of my fingers so I was unable to
use my hands. Then the doctors switched to the "new" medication
Xarelto.I was again able to walk but after a months or so i developed
strong balance disorder . After a few months doctors decided that i
should quit the drug. I asked them if a thin out of the medication is
needed, but they told me that this is not needed and i should
discontinue to take the medication immediately. That´s what I did, but
several days later (10 days) i developed a deep vein thrombosis in my
healthy left leg without being lying or so. I was again treated with
lovenox first and then sintrom. I started to make investigation in the
internet then and found out that in the US it was warned to quit xarelto
without using another anticoagulant parallel .Until today it is not
written on the instruction leaflet.In autumn 2014 I developed a lung
emboly and was again treated with lovenox first which led to strong
muscle weakness, after approx. 3 months the doctors switched again to
xarelto. at first everything was fine but after 6 months i developed
muscle spasm and balance disorder.After Reha of 6 weeks the effect is
still there, all other medical causes have been excluded. These side
effects are again well known in the US but have again been hidden by the
Pharma company in Europe as it is not written on the instruction leaflet
My question now is: when was the first time the side effect "muscle
weakness" of lovenox was recognized in The US, and when was first warned
that premature discontinuation of xarelto can lead to thrombosis or
emboly without using another anticoagulant parallel? When was the first
time the side effects of Xarelto(balance disorder, muscle spasm) being
known in the US?
Do you think that these companies are guilty for not publishing the data
in Europe for such a long time?Do you think that i can claim against the
producers of lovenox in the US for hiding this information in Europe,
the same for Bayers xarelto?
best regards Manuel Stuettler, Mycologist
I need legal help I took the medication trajenta abd now I have acute pancreatitis the doctor told me they can't save my pancrease please call me
Dr prescribed me Glyburide for gestational diabetes. My son developed rare side effect low platelet levels "ITP".
ADD YOUR COMMENT ON THIS ISSUE